Product
PTM F/TAF
1 clinical trial
1 indication
Clinical trial
A Phase 3, Double-Blinded, Multicenter, Randomized Study to Evaluate Safety and Efficacy of Twice Yearly Long-Acting Subcutaneous Lenacapavir, and Daily Oral Emtricitabine/Tenofovir Alafenamide for Pre-Exposure Prophylaxis in Adolescent Girls and Young Women at Risk of HIV InfectionStatus: Active (not recruiting), Estimated PCD: 2024-09-01